Lista de obras - John Gierula - Dominio Público Uruguay

47 Using Natriuretic Peptide Levels to Diagnose Heart Failure in Primary Care: An Evaluation of the 2010 United Kingdom National Institute of Clinical Excellence Guidelines on the Diagnosis of Chronic Heart Failure

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure ⬇️

artículo científico publicado en 2015

Association of heart failure and its comorbidities with loss of life expectancy

artículo científico publicado en 2020

Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure. ⬇️

artículo científico publicado en 2014

Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction

scientific article published on 27 August 2020

Cardiac magnetic resonance in patients with cardiac resynchronization therapy: is it time to scan with resynchronization on? ⬇️

artículo científico publicado en 2019

Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction ⬇️

artículo científico publicado en 2013

Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator

artículo científico publicado en 2017

Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology

artículo científico publicado en 2019

Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart Failure ⬇️

artículo científico publicado en 2016

Devices in heart failure; diagnosis, detection and disease modification. ⬇️

artículo científico publicado en 2018

Divergent skeletal muscle mitochondrial phenotype between male and female patients with chronic heart failure

artículo científico publicado en 2019

Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fraction

artículo científico publicado en 2020

Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study ⬇️

artículo científico publicado en 2016

Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in pacemaker recipients

artículo científico publicado en 2020

Infection-Related Hospitalization in Heart Failure With Reduced Ejection Fraction: A Prospective Observational Cohort Study

scientific article published on 01 May 2020

Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction ⬇️

artículo científico publicado en 2018

Long-term performance of left ventricular leads in cardiac resynchronisation therapy

artículo científico publicado en 2020

Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes ⬇️

artículo científico publicado en 2017

Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial

scientific article published on 17 July 2019

Pacing-associated left ventricular dysfunction? Think reprogramming first!

artículo científico publicado en 2014

Patients with long-term permanent pacemakers have a high prevalence of left ventricular dysfunction ⬇️

artículo científico

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification ⬇️

artículo científico publicado en 2016

Personalised Rate-Response Programming Improves Exercise Tolerance After Six Months in People with Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study

artículo científico publicado en 2020

Predicting one‐year mortality in heart failure using the ‘Surprise Question’: a prospective pilot study ⬇️

scientific article published on 11 December 2018

Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction ⬇️

artículo científico publicado en 2018

Prioritizing symptom management in the treatment of chronic heart failure

scientific article published on 05 August 2020

Prognostic Significance of Incidental Non-Sustained Ventricular Tachycardia Detected on Pacemaker Interrogation ⬇️

artículo científico publicado en 2018

Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary care ⬇️

Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart Failure ⬇️

artículo científico publicado en 2017

Reply

Response by Gierula et al to Letter Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study"

artículo científico publicado en 2020

Response to (resynchronization) therapy in chronic heart failure: time for a different approach

artículo científico publicado en 2014

Septal pacing: still no clarity?

artículo científico publicado en 2013

The prognostic value of cardiovascular magnetic resonance in aborted sudden cardiac death

artículo científico publicado en 2015

Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy

artículo científico publicado en 2020

Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure

artículo científico publicado en 2018

Optimisation of pacemaker therapy for cardiac function ⬇️

tesis doctoral

Lista de obras de John Gierula

47 Using Natriuretic Peptide Levels to Diagnose Heart Failure in Primary Care: An Evaluation of the 2010 United Kingdom National Institute of Clinical Excellence Guidelines on the Diagnosis of Chronic Heart Failure

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure ⬇️

Association of heart failure and its comorbidities with loss of life expectancy

Calcium, phosphate and calcium phosphate product are markers of outcome in patients with chronic heart failure. ⬇️

Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction

Cardiac magnetic resonance in patients with cardiac resynchronization therapy: is it time to scan with resynchronization on? ⬇️

Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction ⬇️

Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator

Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology

Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart Failure ⬇️

Devices in heart failure; diagnosis, detection and disease modification. ⬇️

Divergent skeletal muscle mitochondrial phenotype between male and female patients with chronic heart failure

Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fraction

Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study ⬇️

Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in pacemaker recipients

Infection-Related Hospitalization in Heart Failure With Reduced Ejection Fraction: A Prospective Observational Cohort Study

Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction ⬇️

Long-term performance of left ventricular leads in cardiac resynchronisation therapy

Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes ⬇️

Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial

Pacing-associated left ventricular dysfunction? Think reprogramming first!

Patients with long-term permanent pacemakers have a high prevalence of left ventricular dysfunction ⬇️

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification ⬇️

Personalised Rate-Response Programming Improves Exercise Tolerance After Six Months in People with Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study

Predicting one‐year mortality in heart failure using the ‘Surprise Question’: a prospective pilot study ⬇️

Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction ⬇️

Prioritizing symptom management in the treatment of chronic heart failure

Prognostic Significance of Incidental Non-Sustained Ventricular Tachycardia Detected on Pacemaker Interrogation ⬇️

Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary care ⬇️

Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart Failure ⬇️

Reply

Response by Gierula et al to Letter Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study"

Response to (resynchronization) therapy in chronic heart failure: time for a different approach

Septal pacing: still no clarity?

The prognostic value of cardiovascular magnetic resonance in aborted sudden cardiac death

Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy

Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure

Optimisation of pacemaker therapy for cardiac function ⬇️